Medically reviewed by Dr Ahmed Haq, Medical Director, Cosmedocs Harley StreetGMC 6078057Last reviewed

    Skin science · Ageing

    Written by the Cosmedocs Clinical Team · Doctor-led aesthetic medicine, Harley Street

    The ageing curve has gears.

    Ageing is not a neat, equal deduction every birthday. Patients describe it as happening "suddenly", and — for once — the science is beginning to agree with them.

    Conceptual clinical graphic of a non-linear ageing curve with two peaks and a shaded menopausal transition band

    The short answer

    Ageing has a slow baseline punctuated by faster windows. The best-established of these is the menopausal transition, where reviews report that up to around 30% of dermal collagen may be lost in the first five years, then roughly 2% per year afterwards. Molecular profiling work has also proposed clusters of accelerated change around the mid-forties and around sixty, in both sexes. The practical consequence is simple: age is the number on the chart, but stage is where you sit on the curve — and treatment should be planned around stage.

    Why "it happened overnight" is not vanity talking

    One of the most common things said in a Harley Street consulting room is some version of: "I looked fine last year." Traditionally that has been filed under perception — a bad photograph, a difficult year, a mirror at the wrong angle. It is increasingly clear that the perception is tracking something real.

    If ageing were a straight line, every year would cost the same. Skin would thin at a constant rate, fat pads would deflate on a schedule, and bone would resorb evenly. That is not what we see across a caseload of thousands of faces. We see long, unremarkable stretches in which very little changes, and shorter periods in which several things change at once — skin quality, jaw definition, the tear trough, the corner of the mouth. The face does not decline; it steps down.

    The window with the strongest evidence: menopause

    Oestrogen is not merely a reproductive hormone; it is a skin hormone. Oestrogen receptors are present in dermal fibroblasts, and oestrogen influences collagen synthesis, dermal thickness, hyaluronic acid content and wound healing. When oestrogen falls, the dermis loses its most reliable supporter.

    The figure reported across reviews is striking and consistent: up to around 30% of dermal collagen may be lost in the first five years following menopause, with a further decline of approximately 2% per year thereafter. Read that again as a patient rather than a statistic. It means the majority of the loss is front-loaded into a short window, and then the curve flattens into a slow annual drip.

    That is exactly why women describe the change as abrupt. It is comparatively abrupt. Crepey skin on the neck and décolletage, a sudden loss of the light-reflecting quality in the cheek, jewellery-fine lines on the upper lip and a jawline that softens within two seasons are typical of this window rather than of ageing generally.

    The proposed gears: the mid-forties and around sixty

    Longitudinal molecular profiling — following individuals over years and measuring thousands of proteins, lipids and metabolites — has suggested that human ageing is not gradual at the molecular level either. Two clusters of non-linear change have been proposed: one around the mid-forties and one around the sixtieth year.

    The mid-forties cluster is the interesting one, because it appears in men as well as women, which argues against a purely menopausal explanation. It has been associated with changes in lipid and alcohol metabolism, cardiovascular markers, and — relevant to us — skin and muscle proteins. The later cluster around sixty has been associated with immune regulation, carbohydrate metabolism and kidney function.

    We are deliberately careful with our language here. This is an evolving hypothesis from a small number of participants, not an established clinical law. The menopausal collagen window is far better supported. Any clinic presenting the molecular "waves" as settled fact is over-claiming, and over-claiming is how patients end up treated for a chart rather than for a face.

    What this changes in practice

    If ageing were linear, the sensible strategy would be a constant, unchanging maintenance schedule. Because it is not, the strategy should change shape as you cross each window.

    Before the first gear — protection is cheaper than reconstruction

    In the thirties and early forties, most faces do not need volume. They need collagen preserved: daily sun protection, a tolerated retinoid, adequate protein and sleep, and — where appropriate — regenerative work such as skin rejuvenation with Profhilo or polynucleotides that supports the dermis rather than inflating it. This is the least glamorous and highest-yield period of all.

    Through the acceleration — treat quality, not shape

    During and after the menopausal transition, the dominant problem is usually tissue quality and laxity, not lost volume. This matters, because filling a lax face makes it heavier rather than younger. Collagen-stimulating and tightening approaches — including Endolaser fibre-laser tightening and PDO threads where there is genuine descent — tend to read better than volume alone. Where volume has genuinely gone, it should be replaced with structure in mind, as we set out in our guide to jawline change after thirty.

    After the curve flattens — small, regular, unremarkable

    Once the steep section has passed, the annual loss is modest. That is an argument for smaller, more frequent, less dramatic intervention. Faces that age well over a decade are rarely the ones that had the most done; they are the ones that never fell far behind.

    Age is the number. Stage is the curve.

    Two women at fifty-two can be five years apart in tissue terms, depending on menopausal timing, sun exposure, smoking history, weight fluctuation, genetics and sleep. Treating both to the same protocol because the birth certificates match is how faces end up looking treated rather than well.

    This is why we assess stage in clinic rather than reading an age off a form — and why we would rather do very little in a stable phase than fill a face on schedule. If you want a neutral starting point, you can map your own facial proportions before you speak to anyone. It maps; it does not score.

    Our aesthetics is invisible art. Understanding when your face is actually changing — and when it is not — is what makes the result quiet rather than loud.

    Frequently asked questions

    Does ageing really happen in bursts rather than gradually?

    Partly. Chronological ageing is steady, but the visible and biological pace of change is not. Large molecular profiling work has proposed clusters of accelerated change around the mid-forties and around sixty, and the loss of dermal collagen after menopause is comparatively well established. Between those windows, change is slower and more linear. So the honest position is: gradual baseline, with periods where the pace picks up.

    How much collagen is lost after menopause?

    Reviews consistently report that up to around 30% of dermal collagen may be lost in the first five years after menopause, followed by roughly 2% per year thereafter. That is why skin can feel as though it changed within a couple of years rather than over a decade — the deduction is front-loaded, not spread evenly.

    Is the mid-forties change only about hormones?

    No. The proposed mid-forties cluster appears in both men and women, which suggests it is not purely a menopausal phenomenon. It has been associated with shifts in lipid and alcohol metabolism, cardiovascular markers and skin and muscle proteins. It should still be treated as an evolving hypothesis rather than settled fact.

    Should I start treatment earlier because of this?

    Earlier does not mean more. It means better timed and lighter. Protecting collagen you still have — with sun protection, retinoids, adequate protein and sleep, and where appropriate regenerative treatments — is easier than rebuilding it. The mistake is not starting at forty; it is treating at fifty as though nothing changed at forty-five.

    Does this mean HRT will keep my skin young?

    Skin is one of many considerations in a menopause discussion, and it is not a reason on its own to start or avoid hormone therapy. That is a conversation for your GP or menopause specialist, based on your full medical picture. What we can say is that the post-menopausal collagen window is real, and planning skin care around it is sensible.

    How do I know which stage I am at?

    Age tells you the number on the chart. Stage tells you where you sit on the curve — how much volume, skin quality and laxity have actually changed. Two people at fifty can be a decade apart in tissue terms. That assessment is what a proper consultation is for.

    Your consultation begins here

    Find out which stage you are actually at

    A proper assessment looks at skin quality, laxity, volume and structure separately — then treats only what has genuinely changed.

    Book a consultation

    Evidence note

    The menopausal dermal collagen figures quoted here are drawn from published review literature on oestrogen and skin ageing. The proposed mid-forties and sixty molecular clusters come from longitudinal multi-omic profiling research and should be treated as an evolving hypothesis rather than established clinical fact. This article is general information for adults and is not a substitute for individual medical advice. Written and reviewed by the Cosmedocs Clinical Team.